Non-alcoholic fatty liver disease: What's in our arsenal?

Jaividhya Dasarathy; Sanath Allampati; Christine Alexander; Arthur McCullough

Non-alcoholic fatty liver disease: What's in our arsenal?

J Fam Pract. 2016 Apr;65(4):239-44.

Authors

Jaividhya Dasarathy¹, Sanath Allampati², Christine Alexander³, Arthur McCullough⁴

Affiliations

¹ Department of Family Medicine, Metrohealth Medical Center, Cleveland, OH, USA. Email: jdasarathy@metrohealth.org.
² Department of Hospital Medicine, Cleveland Clinic Foundation, OH, USA.
³ Department of Family Medicine, Metrohealth Medical Center, Cleveland, OH, USA.
⁴ Department of Gastroenterology and Hepatology, Cleveland Clinic, OH, USA.

PMID: 27262247

Abstract

Lifestyle changes and metabolic syndrome management are the best interventions for NAFLD. Less clear is which agents to use for liver-directed pharmacotherapy.

Publication types

Case Reports

MeSH terms

Adult
Humans
Hypolipidemic Agents / therapeutic use*
Life Style
Male
Metabolic Syndrome / prevention & control*
Non-alcoholic Fatty Liver Disease / diagnosis*
Non-alcoholic Fatty Liver Disease / drug therapy*
Obesity / prevention & control*
Risk Factors
Treatment Outcome
United States

Substances

Hypolipidemic Agents